Search Results for: APP

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PDCD7 programmed cell death 7
  • mRNA Splicing - Minor Pathway
PDE1A phosphodiesterase 1A
  • Cam-PDE 1 activation
  • cGMP effects
  • G alpha (s) signalling events
  • Caffeine
  • Nicardipine
  • Felodipine
  • Bepridil
  • Trapidil
PDE4D phosphodiesterase 4D
  • DARPP-32 events
  • G alpha (s) signalling events
  • Adenosine phosphate
  • Caffeine
  • Caffeine
  • Dyphylline
  • Iloprost
  • Papaverine
  • Amrinone
  • Roflumilast
  • Piclamilast
  • Rolipram
  • Rolipram
  • 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol
  • Zardaverine
  • 1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • (S)-Rolipram
  • Cilomilast
  • (R)-Rolipram
  • 3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • Crisaborole
  • Ibudilast
  • Tetomilast
  • Exisulind
  • (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
  • 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
  • 3-isobutyl-1-methyl-7H-xanthine
  • 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
  • Trapidil
PDE6H phosphodiesterase 6H
  • Sildenafil
  • Vardenafil
  • Cone-rod dystrophy and cone dystrophy, including: Cone-rod dystrophy (CORD); Cone dystrophy (COD); Retinal cone dystrophy (RCD)
PDIA3 protein disulfide isomerase family A member 3
  • ER-Phagosome pathway
  • ER-Phagosome pathway
  • Calnexin/calreticulin cycle
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Zinc
  • Copper
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
PDK3 pyruvate dehydrogenase kinase 3
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Signaling by Retinoic Acid
  • Radicicol
  • Dihydrolipoic Acid
PDPK1 3-phosphoinositide dependent protein kinase 1
  • GPVI-mediated activation cascade
  • GPVI-mediated activation cascade
  • PIP3 activates AKT signaling
  • Activation of AKT2
  • Downstream TCR signaling
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • FCERI mediated NF-kB activation
  • Integrin signaling
  • CD28 dependent PI3K/Akt signaling
  • G beta:gamma signalling through PI3Kgamma
  • RSK activation
  • VEGFR2 mediated vascular permeability
  • VEGFR2 mediated cell proliferation
  • CLEC7A (Dectin-1) signaling
  • RHO GTPases activate PKNs
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Regulation of TP53 Degradation
  • Estrogen-stimulated signaling through PRKCZ
  • Estrogen-stimulated signaling through PRKCZ
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • Celecoxib
  • Inositol 1,3,4,5-Tetrakisphosphate
  • 7-Hydroxystaurosporine
  • Bisindolylmaleimide VIII
  • Staurosporine
  • Bisindolylmaleimide I
  • Dexfosfoserine
  • 10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine
  • 5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE
  • 1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA
  • 2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine
  • 3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione
  • 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE
  • Fostamatinib
PDS5B PDS5 cohesin associated factor B
  • Separation of Sister Chromatids
  • Establishment of Sister Chromatid Cohesion
  • Cohesin Loading onto Chromatin
  • Resolution of Sister Chromatid Cohesion
PDSS2 decaprenyl diphosphate synthase subunit 2
  • Ubiquinol biosynthesis
  • Coenzyme Q10 deficiency
PDYN prodynorphin
  • Opioid Signalling
  • G-protein activation
  • Peptide ligand-binding receptors
  • G alpha (i) signalling events
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
PDZD4 PDZ domain containing 4
PDZD9 PDZ domain containing 9
PDZK1 PDZ domain containing 1
PEG3 paternally expressed 3
PELI3 pellino E3 ubiquitin protein ligase family member 3
  • Interleukin-1 signaling
  • IRAK1 recruits IKK complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
PES1 pescadillo ribosomal biogenesis factor 1
  • Major pathway of rRNA processing in the nucleolus and cytosol
PEX2 peroxisomal biogenesis factor 2
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Peroxisomal protein import
  • Peroxisomal protein import
  • Class I peroxisomal membrane protein import
  • Zellweger syndrome spectrum, including: Zellweger syndrome (ZS); Adrenoleukodystrophy, neonatal (NALD); Infantile Refsum disease (IRD)
PFKFB1 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
  • PKA-mediated phosphorylation of key metabolic factors
  • PP2A-mediated dephosphorylation of key metabolic factors
  • Regulation of glycolysis by fructose 2,6-bisphosphate metabolism
  • Regulation of glycolysis by fructose 2,6-bisphosphate metabolism
  • D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate
  • sn-glycerol 3-phosphate
  • Adenosine 5'-[gamma-thio]triphosphate
  • Guanosine-5'-Triphosphate
  • Fructose-6-phosphate
PFKL phosphofructokinase, liver type
  • Neutrophil degranulation
  • Glycolysis
PGM1 phosphoglucomutase 1
  • Glycogen synthesis
  • Defective PGM1 causes PGM1-CDG
  • Neutrophil degranulation
  • Glycogen breakdown (glycogenolysis)
  • Galactose catabolism
  • Alpha-D-Glucose 1,6-Bisphosphate
  • Alpha-D-Glucose-1-Phosphate-6-Vanadate

Page 66 out of 106 pages